The main signaling pathways associated with breast cancer transformation and progression (Figure 1) depend on the expression of the estrogen receptor and its associated signaling—ER alpha (ERα—a membrane receptor) and ER beta (ERβ—a nuclear receptor) [13,14,15,16]. This evidence concerns the gene ESR2 and breast carcinoma.